Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
SIRO's Cash to Debt is ranked higher than
97% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. SIRO: No Debt )
Ranked among companies with meaningful Cash to Debt only.
SIRO' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.94 Max: No Debt
Current: No Debt
Equity to Asset 0.70
SIRO's Equity to Asset is ranked higher than
70% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. SIRO: 0.70 )
Ranked among companies with meaningful Equity to Asset only.
SIRO' s 10-Year Equity to Asset Range
Min: -0.11  Med: 0.53 Max: 0.88
Current: 0.7
-0.11
0.88
Interest Coverage No Debt
SIRO's Interest Coverage is ranked higher than
95% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. SIRO: No Debt )
Ranked among companies with meaningful Interest Coverage only.
SIRO' s 10-Year Interest Coverage Range
Min: 1.68  Med: 24.27 Max: 9999.99
Current: No Debt
1.68
9999.99
F-Score: 6
Z-Score: 7.89
M-Score: -2.71
WACC vs ROIC
7.53%
21.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 21.94
SIRO's Operating margin (%) is ranked higher than
87% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. SIRO: 21.94 )
Ranked among companies with meaningful Operating margin (%) only.
SIRO' s 10-Year Operating margin (%) Range
Min: -66.23  Med: 16.63 Max: 35.85
Current: 21.94
-66.23
35.85
Net-margin (%) 16.01
SIRO's Net-margin (%) is ranked higher than
87% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. SIRO: 16.01 )
Ranked among companies with meaningful Net-margin (%) only.
SIRO' s 10-Year Net-margin (%) Range
Min: -64.92  Med: 12.66 Max: 45.97
Current: 16.01
-64.92
45.97
ROE (%) 14.53
SIRO's ROE (%) is ranked higher than
80% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. SIRO: 14.53 )
Ranked among companies with meaningful ROE (%) only.
SIRO' s 10-Year ROE (%) Range
Min: -290.68  Med: 13.98 Max: 227.81
Current: 14.53
-290.68
227.81
ROA (%) 10.17
SIRO's ROA (%) is ranked higher than
82% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. SIRO: 10.17 )
Ranked among companies with meaningful ROA (%) only.
SIRO' s 10-Year ROA (%) Range
Min: -73.05  Med: 7.83 Max: 68.42
Current: 10.17
-73.05
68.42
ROC (Joel Greenblatt) (%) 85.38
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. SIRO: 85.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SIRO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -442.18  Med: 86.32 Max: 275.82
Current: 85.38
-442.18
275.82
Revenue Growth (3Y)(%) 9.30
SIRO's Revenue Growth (3Y)(%) is ranked higher than
73% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. SIRO: 9.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SIRO' s 10-Year Revenue Growth (3Y)(%) Range
Min: -23.4  Med: 9.75 Max: 71.9
Current: 9.3
-23.4
71.9
EBITDA Growth (3Y)(%) 8.70
SIRO's EBITDA Growth (3Y)(%) is ranked higher than
55% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. SIRO: 8.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SIRO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -30.1  Med: 21.75 Max: 84
Current: 8.7
-30.1
84
EPS Growth (3Y)(%) 13.70
SIRO's EPS Growth (3Y)(%) is ranked higher than
60% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. SIRO: 13.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SIRO' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.9  Med: 14.80 Max: 59
Current: 13.7
-8.9
59
» SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

SIRO Guru Trades in Q3 2014

Dodge & Cox 3,405 sh (New)
John Burbank 48,670 sh (New)
Chuck Royce 5,380 sh (+417.31%)
Jeremy Grantham 76,116 sh (+73.78%)
Paul Tudor Jones Sold Out
Ruane Cunniff 2,833,679 sh (-0.61%)
Ron Baron 74,903 sh (-7.75%)
Columbia Wanger 950,000 sh (-22.00%)
» More
Q4 2014

SIRO Guru Trades in Q4 2014

Joel Greenblatt 37,067 sh (New)
Ruane Cunniff 2,827,172 sh (unchged)
Dodge & Cox 3,405 sh (unchged)
John Burbank Sold Out
Ruane Cunniff 2,827,172 sh (-0.23%)
Ron Baron 67,403 sh (-10.01%)
Jeremy Grantham 67,400 sh (-11.45%)
Chuck Royce 3,480 sh (-35.32%)
Columbia Wanger 575,231 sh (-39.45%)
» More
Q1 2015

SIRO Guru Trades in Q1 2015

Columbia Wanger 575,231 sh (unchged)
Ron Baron 67,403 sh (unchged)
Ruane Cunniff 2,827,202 sh (unchged)
Chuck Royce Sold Out
Dodge & Cox Sold Out
Joel Greenblatt Sold Out
Jeremy Grantham 64,800 sh (-3.86%)
» More
Q2 2015

SIRO Guru Trades in Q2 2015

Joel Greenblatt 8,577 sh (New)
Columbia Wanger 611,440 sh (+6.29%)
Ruane Cunniff 2,841,520 sh (+0.51%)
Ron Baron 63,252 sh (-6.16%)
Jeremy Grantham 48,900 sh (-24.54%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.50
SIRO's P/E(ttm) is ranked lower than
51% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. SIRO: 29.50 )
Ranked among companies with meaningful P/E(ttm) only.
SIRO' s 10-Year P/E(ttm) Range
Min: 9.38  Med: 26.56 Max: 766.86
Current: 29.5
9.38
766.86
Forward P/E 21.74
SIRO's Forward P/E is ranked higher than
51% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. SIRO: 21.74 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.50
SIRO's PE(NRI) is ranked lower than
55% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. SIRO: 29.50 )
Ranked among companies with meaningful PE(NRI) only.
SIRO' s 10-Year PE(NRI) Range
Min: 9.34  Med: 26.53 Max: 782.2
Current: 29.5
9.34
782.2
P/B 4.19
SIRO's P/B is ranked lower than
65% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. SIRO: 4.19 )
Ranked among companies with meaningful P/B only.
SIRO' s 10-Year P/B Range
Min: 0.84  Med: 3.24 Max: 11.6
Current: 4.19
0.84
11.6
P/S 4.73
SIRO's P/S is ranked lower than
67% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. SIRO: 4.73 )
Ranked among companies with meaningful P/S only.
SIRO' s 10-Year P/S Range
Min: 0.74  Med: 3.40 Max: 7.44
Current: 4.73
0.74
7.44
PFCF 28.39
SIRO's PFCF is ranked higher than
52% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. SIRO: 28.39 )
Ranked among companies with meaningful PFCF only.
SIRO' s 10-Year PFCF Range
Min: 9.65  Med: 21.33 Max: 99.96
Current: 28.39
9.65
99.96
POCF 21.73
SIRO's POCF is ranked lower than
60% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. SIRO: 21.73 )
Ranked among companies with meaningful POCF only.
SIRO' s 10-Year POCF Range
Min: 5.89  Med: 15.96 Max: 115.33
Current: 21.73
5.89
115.33
EV-to-EBIT 19.99
SIRO's EV-to-EBIT is ranked lower than
53% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. SIRO: 19.99 )
Ranked among companies with meaningful EV-to-EBIT only.
SIRO' s 10-Year EV-to-EBIT Range
Min: 9.1  Med: 18.75 Max: 92.6
Current: 19.99
9.1
92.6
PEG 2.66
SIRO's PEG is ranked higher than
50% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. SIRO: 2.66 )
Ranked among companies with meaningful PEG only.
SIRO' s 10-Year PEG Range
Min: 0.39  Med: 1.88 Max: 18.7
Current: 2.66
0.39
18.7
Shiller P/E 37.58
SIRO's Shiller P/E is ranked lower than
63% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. SIRO: 37.58 )
Ranked among companies with meaningful Shiller P/E only.
SIRO' s 10-Year Shiller P/E Range
Min: 12.06  Med: 39.72 Max: 143.89
Current: 37.58
12.06
143.89
Current Ratio 2.76
SIRO's Current Ratio is ranked higher than
61% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. SIRO: 2.76 )
Ranked among companies with meaningful Current Ratio only.
SIRO' s 10-Year Current Ratio Range
Min: 0.75  Med: 2.18 Max: 8.27
Current: 2.76
0.75
8.27
Quick Ratio 2.31
SIRO's Quick Ratio is ranked higher than
68% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. SIRO: 2.31 )
Ranked among companies with meaningful Quick Ratio only.
SIRO' s 10-Year Quick Ratio Range
Min: 0.17  Med: 1.72 Max: 7.7
Current: 2.31
0.17
7.7
Days Inventory 92.52
SIRO's Days Inventory is ranked higher than
73% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. SIRO: 92.52 )
Ranked among companies with meaningful Days Inventory only.
SIRO' s 10-Year Days Inventory Range
Min: 41.2  Med: 78.77 Max: 182.58
Current: 92.52
41.2
182.58
Days Sales Outstanding 58.58
SIRO's Days Sales Outstanding is ranked higher than
58% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. SIRO: 58.58 )
Ranked among companies with meaningful Days Sales Outstanding only.
SIRO' s 10-Year Days Sales Outstanding Range
Min: 16.78  Med: 39.31 Max: 96.57
Current: 58.58
16.78
96.57

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 21.06
SIRO's Price/Net Current Asset Value is ranked lower than
82% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.89 vs. SIRO: 21.06 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SIRO' s 10-Year Price/Net Current Asset Value Range
Min: 4  Med: 7.97 Max: 3510
Current: 21.06
4
3510
Price/Tangible Book 11.14
SIRO's Price/Tangible Book is ranked lower than
87% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. SIRO: 11.14 )
Ranked among companies with meaningful Price/Tangible Book only.
SIRO' s 10-Year Price/Tangible Book Range
Min: 1  Med: 8.45 Max: 198.23
Current: 11.14
1
198.23
Price/Projected FCF 1.90
SIRO's Price/Projected FCF is ranked lower than
55% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. SIRO: 1.90 )
Ranked among companies with meaningful Price/Projected FCF only.
SIRO' s 10-Year Price/Projected FCF Range
Min: 0.53  Med: 1.54 Max: 12.81
Current: 1.9
0.53
12.81
Price/DCF (Earnings Based) 1.37
SIRO's Price/DCF (Earnings Based) is ranked higher than
63% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.72 vs. SIRO: 1.37 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.39
SIRO's Price/Median PS Value is ranked lower than
67% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. SIRO: 1.39 )
Ranked among companies with meaningful Price/Median PS Value only.
SIRO' s 10-Year Price/Median PS Value Range
Min: 0.04  Med: 0.88 Max: 2.19
Current: 1.39
0.04
2.19
Price/Peter Lynch Fair Value 3.39
SIRO's Price/Peter Lynch Fair Value is ranked lower than
85% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. SIRO: 3.39 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
SIRO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48  Med: 1.87 Max: 30.26
Current: 3.39
0.48
30.26
Price/Graham Number 3.79
SIRO's Price/Graham Number is ranked lower than
71% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. SIRO: 3.79 )
Ranked among companies with meaningful Price/Graham Number only.
SIRO' s 10-Year Price/Graham Number Range
Min: 0.7  Med: 3.26 Max: 14.32
Current: 3.79
0.7
14.32
Earnings Yield (Greenblatt) (%) 5.00
SIRO's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. SIRO: 5.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SIRO' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.1  Med: 5.30 Max: 10.9
Current: 5
1.1
10.9
Forward Rate of Return (Yacktman) (%) 11.31
SIRO's Forward Rate of Return (Yacktman) (%) is ranked lower than
52% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. SIRO: 11.31 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SIRO' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 2  Med: 21.25 Max: 56
Current: 11.31
2
56

Analyst Estimate

Sep15 Sep16
EPS($) 4.00 4.43
EPS without NRI($) 4.00 4.43

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RXT.Germany,
Sirona Dental Systems Inc was founded in 1997 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, technologically-advanced dental equipment, and is engaged in developing, manufacturing and marketing innovative solutions for dentists around the world. The Company provides a range of technologically advanced products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The global dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the worldwide market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise a range of products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 480 distributors. The Companys registered trademarks include, Sirona, CEREC, Orthophos, Heliodent, inLab, CDR, and Schick. It competes with different companies which include large international companies as well as smaller companies that compete regionally or
» More Articles for SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Reports Fiscal 2009 Third Quarter and Year-to-Date Results Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
SIRONA DENTAL SYSTEMS, INC. Financials Aug 15 2015
Sirona Dental Beats on Q3 Earnings: Muted Show by Stock - Analyst Blog Aug 10 2015
10-Q for Sirona Dental Systems, Inc. Aug 09 2015
Edited Transcript of SIRO earnings conference call or presentation 7-Aug-15 12:30pm GMT Aug 07 2015
4 Stocks, 4 trades: INTC, SIRO, ZNGA & GRPN Aug 07 2015
Sirona Dental Systems Inc Earnings Call scheduled for 8:30 am ET today Aug 07 2015
Q3 2015 Sirona Dental Systems Inc Earnings Release - Before Market Open Aug 07 2015
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2015
Sirona Dental tops Street 3Q forecasts Aug 07 2015
Sirona Dental tops Street 3Q forecasts Aug 07 2015
Sirona Reports Record Fiscal 2015 Third Quarter Results Aug 07 2015
Align Technology, Inc. Earnings Analysis: By the Numbers Jul 30 2015
Intuitive Surgical, Inc. Earnings Analysis: By the Numbers Jul 27 2015
Sirona to Report Third Quarter Fiscal 2015 Results on August 7th Jul 24 2015
Halftime Portfolio: 2015 bets Jul 01 2015
Sirona Hits 52-Week High on Positive View, Strong Pipeline - Analyst Blog Jun 19 2015
Sirona and OnDemand 3D Enter Into A Settlement and License Agreement For Dental Surgical Drill... May 19 2015
Sirona Q2 Earnings Meet, Revenues Lag; View Maintained - Analyst Blog May 13 2015
Sirona Dental Systems Inc Earnings Call scheduled for 8:30 am ET today May 08 2015
Sirona Dental meets 2Q profit forecasts May 08 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK